Compare NVX & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVX | AGL |
|---|---|---|
| Founded | 2012 | 2016 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Managed Health Care |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.7M | 276.6M |
| IPO Year | N/A | 2021 |
| Metric | NVX | AGL |
|---|---|---|
| Price | $1.12 | $0.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 17 |
| Target Price | N/A | ★ $2.79 |
| AVG Volume (30 Days) | 1.6M | ★ 13.4M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,931,433.00 | ★ $5,885,571,000.00 |
| Revenue This Year | $165.90 | N/A |
| Revenue Next Year | $1,344.85 | $5.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.21 |
| 52 Week Low | $0.81 | $0.51 |
| 52 Week High | $3.86 | $6.08 |
| Indicator | NVX | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 42.12 | 48.61 |
| Support Level | $1.05 | $0.62 |
| Resistance Level | $1.20 | $0.68 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 55.36 | 91.51 |
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.